Weight variability and diabetes complications

Diabetes Res Clin Pract. 2023 May:199:110646. doi: 10.1016/j.diabres.2023.110646. Epub 2023 Mar 29.

Abstract

Body weight is a recognized risk factor for cardiovascular diseases (CVD). More recently, weight variability, i.e. the oscillation of body weight over time, has also been suggested to be independently associated with development of CVD and mortality in subjects without diabetes and in people with both type 1 and type 2 diabetes (T2D). In T2D, weight variability emerged as one of the most relevant risk factors for CVD and it was suggested to interact with the variability of other risk factors to identify people at high cardiovascular risk. In addition, weight variability seems also to confer a higher risk for microvascular complications in people with T2D. While the exact mechanism linking weight variability to CVD is unknown, evidence from experimental models suggests that weight cycling promote an enduring pro-inflammatory program in the adipose tissue. Here we review the clinical evidence relative to the association of weight variability with CVD and microvascular complications of diabetes. We then briefly summarize the alterations proposed to explain this association. Finally, we synthesize the possible strategies, e.g. specific dietetic regimens and available glucose-lowering drugs, to minimize weight fluctuations.

Keywords: BMI; Body weight; Cardiovascular diseases; Diabetes; Microvascular complications; Obesity; Oscillations; Variability.

Publication types

  • Review

MeSH terms

  • Body Weight
  • Cardiovascular Diseases* / complications
  • Cardiovascular Diseases* / etiology
  • Diabetes Complications* / complications
  • Diabetes Mellitus, Type 2* / complications
  • Humans
  • Risk Factors